ARWR Dividend History & Analysis | N/A Yield
ARWR has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| BTX | 1,406 M | 13.3% | 7.37% |
| ABBV | 403,830 M | 3.70% | 9.39% |
| AMGN | 176,250 M | 3.65% | 5.91% |
| GILD | 150,882 M | 2.60% | 6.07% |
| HLN | 44,530 M | 1.71% | 2.46% |
| Symbol | Market Cap USD | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| BTX | 1,406 M | 134% | 95.6% |
| HLN | 44,530 M | 30.1% | 100% |
| AMGN | 176,250 M | 7.84% | 100% |
| ABBV | 403,830 M | 5.98% | 100% |
| GILD | 150,882 M | 2.71% | 100% |
Similar Stocks with Attractive Dividends - Compare ARWR Dividends with its Peer-Group
3.65% Yield
3.70% Yield
2.60% Yield
1.71% Yield
ARWR Dividend History: as of January 2026
No dividends paid yet.ARWR Dividend FAQ
Arrowhead Pharmaceuticals (NASDAQ: ARWR) focuses on RNA-targeted medicines for hard-to-treat diseases. Its late-stage portfolio includes three Phase 3 candidates-Plozasiran (hypertriglyceridemia, dyslipidemia, familial chylomicronemia syndrome), Olpasiran (apo-A reduction) and Fazirsiran (alpha-1 antitrypsin-related liver disease)-plus a suite of Phase 2/1 programs targeting metabolic, hepatic, pulmonary and rare-disease indications. The company leverages a network of collaborations with GlaxoSmithKline, Horizon Therapeutics, Takeda and Amgen to co-develop and commercialize its RNAi platform.
What is the Dividend Yield of ARWR?
As of January 2026, ARWR`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 70.81.Does ARWR pay a dividend?
As of January 2026 ARWR does not pay a dividend.How often does ARWR pay dividends?
Over the last 12 months, ARWR has issued dividend payments.ARWR dividend forecast
Based on historical data, the forecasted dividends per share for ARWR for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will ARWR pay dividends in 2026?
The next Ex-Dividend date for Arrowhead Pharmaceuticals (ARWR) is currently unknown.What is the next Ex-Dividend Date for ARWR?
The next Ex-Dividend date for Arrowhead Pharmaceuticals (ARWR) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of ARWR?
ARWR's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of ARWR?
ARWR's 5-Year Yield on Cost is -%. If you bought ARWR's shares at 79.88 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of ARWR?
ARWR Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does ARWR have a good Dividend Yield?
ARWR`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of ARWR?
The Dividend Payout Ratio of ARWR is unknown.What is the Dividend Rating of ARWR?
ARWR`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-12-28 02:18